GlassScriptPhysician profile
David Powell Bryant
NPI 1447259528
$1,651.77
in general payments reported to CMS, 2019-2025
18 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $274 · 2021: $468 · 2022: $115 · 2023: $114 · 2024: $209 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $539.92 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $231.43 | 2024-2025 | |
| Pfizer INC. | $203.31 | 2019-2021 | |
| Glaxosmithkline, LLC. | $182.80 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $113.46 | 2019-2021 | |
| Lilly USA, LLC | $61.55 | 2020-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $47.21 | 2022-2024 | Farxiga, Breztri |
| Amgen INC. | $43.75 | 2023-2024 | Repatha, Otezla |
| Kowa Pharmaceuticals America, INC. | $39.05 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $35.02 | 2021 | |
| Novo Nordisk INC | $30.02 | 2020-2024 | |
| Arbor Pharmaceuticals, INC. | $29.95 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.96 | 2021 | |
| Eisai INC. | $16.81 | 2021 | |
| Abbott Laboratories | $15.79 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.05 | 2019 | |
| Boston Scientific Corporation | $13.66 | 2023 | |
| Pbg Puerto Rico LLC | $10.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.